TrialReader


Use of Microscopy, Cultures and Molecular Biological Methods for Diagnosing Nosocomial Pneumonia

NCT04279873 — Completed, 22 participants, Zealand University Hospital

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Use of Microscopy, Cultures and Molecular Biological Methods for Diagnosing Nosocomial Pneumonia in Patients Admitted to the Intensive Care Unit - an Exploratory Study

RegistryNCT04279873
StatusCompleted
Study typeObservational
Enrollment22 (Actual)
SponsorZealand University Hospital (Other); collaborators: Slagelse Hospital
ConditionsNosocomial Pneumonia
InterventionsMicrobiological diagnostics on pulmonary secretion (Diagnostic test)
Datesstart 2014-05-01, primary completion 2020-12-31, completion 2020-12-31, first posted 2020-02-21, last updated 2021-04-22
Locations1 site in Denmark

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Nosocomial Pneumonia All trials of Microbiological diagnostics on pulmonary secretion

-Summary

Nosocomial pneumonia in the Intensive Care Unit is often not properly diagnosed mainly due to ongoing antimicrobial therapy. The study investigates the feasibility of more advanced diagnostic technics.

Expand all sections  ·  Collapse all

+Detailed description

ICU patients fulfilling the CDC criteria for nosocomial pneumonia and mechanically ventilated for no more than 24 hours are included in the study. The material for the diagnostic procedure is pulmonal secretion collected by 1. suctioning in the tracheal tube and 2. bronchioalveolar lavage. The diagnostic procedures are culturing, 16S and18S gene PCR and subsequent sequencing. The 3 diagnostic methods will be compared in order of proper diagnosis and the ability to determine a specific antimicrobial treatment.

+Arms and interventions

ArmTypeInterventionsDescription
Adults with nosocomial pneumoniaDiagnostic Test: Microbiological diagnostics on pulmonary secretionDiagnostic procedures on pulmonary secretion collected by tracheal suctioning and bronchoalveolar lavage.
  • Microbiological diagnostics on pulmonary secretion (Diagnostic test): Culture, 16s, 18s, next generation sequencing

+Outcome measures

Primary outcomes

  • Ratio of patients where the advanced methods are superior to routine [1 day]: Ratio of patients diagnosed by 16s, 18s or NGS to total number of patients compared to ratio of patients diagnosed by routine method (culture)

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Patients intubated because of respiratory failure following nosocomial pneumonia

Exclusion Criteria:

* Terminal patients
* Patients with lung cancer
* Intubated for more than 24 hours at the sampling time
* Not fulfilling the CDC criteria for nosocomial pneumonia

+Locations (1)

FacilityCityCountryStatus
Zealand University HospitalKøge, Region SjællandDenmark

+Investigators

My Notes